Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Jaritz
    Junior Member
    • Sep 2009
    • 3

    Bioinformatics Data Analyst IMP/IMBA Vienna

    Bioinformatics Data Analyst IMP/IMBA Vienna
    We are looking for a joint/shared Bioinformatics Data Analyst to join the Cochella
    (http://www.imp.ac.at/research/resear...ochella-group/) and Bell
    (http://www.imba.oeaw.ac.at/research/oliver-bell/) research groups, which focus
    on the understanding transcriptional and post-transcriptional regulation of gene
    expression.
    Our groups are part of the Research Institute of Molecular Pathology (IMP) and
    the Institute of Molecular Biotechnology of the Austrian Academy of Science
    (IMBA). Both IMBA and IMP are internationally recognized research institutes
    that focus on molecular medicine, stem cell research and RNA biology. Science
    carried out on campus is absolutely at the top level and we carry a great state-ofthe-
    art infrastructure and the top research programs for the different career-level
    of scientists. IMBA/IMP are located in the Campus Vienna Biocenter, close to the
    city center of Vienna.
    As a bioinformatician, you will:
    (1) contribute to the interpretation of next generation sequencing project data
    (obtained by RNA-Seq, ChIP-Seq, ATAC-Seq, GRO-Seq and Bisulfite DNA-Seq
    amongst others) through the development of workflows and analysis protocols
    using relevant algorithms and tools,
    (2) investigate and implement analysis solutions to new research problems and
    (3) secure the availability of high-throughput data and associated analysis
    results to the researchers.
    You will have access to a community of experienced bioinformaticians on
    campus, and support from a powerful computing cluster and excellent IT
    infrastructure.
    Successful candidates should hold an academic degree / PhD in Bioinformatics,
    Biostatistics or Life Sciences, and several years of experience of
    scripting/programming, preferably in the context of genomic high-throughput data
    analysis. A sound statistical knowledge and fluent programming skills in
    R/Bioconductor and at least one more scripting or high-level programming
    language are essential. Applicants need to be proficient with UNIX-like operating
    systems. SQL/Database experience is a strong plus.
    The job further requires excellent communication skills in English.
    We offer an innovative, team oriented, and highly motivated working atmosphere
    in an international renowned research institute. The salary is commensurate with
    qualifications/experience and includes a comprehensive benefits package.
    Applications, including a letter of motivation describing your particular interest in
    this position and past research experiences, a CV and the names and contact
    details of referees should be sent to:
    Dr. Oliver Bell
    Institute of Molecular Biotechnology
    Dr. Bohr-Gasse 3
    1030 Vienna
    Austria
    Email: [email protected]

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    Yesterday, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:10 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...